Doxorubicin HCl

About Haorui Products Technology Contact
 

 

 

Doxorubicin HCl clinical trial-2
21 Completed Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)
Conditions: Cancer;   Carcinoma
Intervention: Drug: liposomal doxorubicin and docetaxel
22 Active, not recruiting Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Pegylated liposomal doxorubicin (Caelyx);   Drug: Epirubicin
23 Completed Ph 3 Randomized Study of TelcytaŽ + Liposomal Doxorubicin Vs Liposomal Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: TLK286 (Telcyta) HCI for Injection;   Drug: Doxorubicin HCI Liposome Injection
24 Recruiting Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Condition: Sarcoma
Intervention: Drug: temsirolimus (Torisel) plus liposomal doxorubicin (Doxil)
25 Active, not recruiting Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059 AM2)
Condition: Breast Neoplasms
Intervention: Drug: Caelyx (pegylated liposomal doxorubicin; SCH 200746)
26 Completed Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: dexamethasone;   Drug: bortezomib;   Drug: doxorubicin;   Drug: vincristine
27 Completed Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.
Conditions: Sarcoma, Kaposi;   HIV Infections
Intervention: Drug: Doxorubicin hydrochloride (liposomal)
28 Recruiting Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement
Condition: Advanced Cancer
Interventions: Drug: Cisplatin;   Drug: Liposomal Doxorubicin
29 Recruiting Thalidomide and DoxilŽ in Patients With Androgen Independent Prostate Cancer (AIPC)
Condition: Prostate Cancer
Interventions: Drug: Thalidomide;   Drug: DoxilŽ (doxorubicin HCL liposome injection)
30 Terminated CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Condition: Ovarian Neoplasms
Interventions: Drug: CAELYX;   Drug: Paclitaxel HCl
31 Recruiting A Study of Liposomal Doxorubicin With or Without IMC-3G3 in Platinum-refractory or Resistant Advanced Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Biological: IMC-3G3;   Drug: liposomal doxorubicin
32 Recruiting Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: enalapril maleate
33 Completed Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
Conditions: Sarcoma, Kaposi;   HIV Infections
Interventions: Drug: Doxorubicin hydrochloride (liposomal);   Drug: Bleomycin sulfate;   Drug: Vincristine sulfate
34 Completed Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus
Conditions: Adenocarcinoma of Stomach;   Adenocarcinoma of GE Junction;   Adenocarcinoma of Esophagus
Interventions: Drug: Doxorubicin;   Drug: Cisplatin;   Drug: 5-fluorouracil
35 Recruiting Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
Condition: Ovarian Cancer
Interventions: Drug: EC145;   Drug: pegylated liposomal doxorubicin (PLD);   Drug: EC20
36 Active, not recruiting
Has Results 		Thalidomide + Dexamethasone Versus DOXIL (Doxorubicin HCl Liposome Injection) + Thalidomide + Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Conditions: Cancer;   Multiple Myeloma
Interventions: Drug: Thalidomide and dexamethasone;   Drug: Thalidomide and dexamethasone plus DOXIL
37 Active, not recruiting ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
Condition: Malignant Mesothelioma
Interventions: Drug: doxorubicin hydrochloride;   Drug: ranpirnase
38 Recruiting Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma
Condition: Diffuse Large B-Cell Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: liposomal Doxorubicin;   Drug: Vincristin;   Drug: Prednisolone
39 Completed Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: DOXIL;   Drug: Abraxane
40 Recruiting Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
Condition: Adenoid Cystic Carcinoma
Intervention: Drug: doxorubicin and bortezomib

 
  Haorui - Your Partner to Pharmaceutical Success - Copy Right Reserved